<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="dict8/PMC7316359/results/search/disease/results.xml">
  <result pre="10.1371/journal.pcbi.1007989PCOMPBIOL-D-19-01797 : Research Article : Medicine and Health Sciences :" exact="Infectious" post="Diseases : Viral Diseases: Influenza : Biology and life"/>
  <result pre=": Research Article : Medicine and Health Sciences : Infectious" exact="Diseases" post=": Viral Diseases: Influenza : Biology and life sciences"/>
  <result pre="Article : Medicine and Health Sciences : Infectious Diseases :" exact="Viral" post="Diseases: Influenza : Biology and life sciences : Organisms"/>
  <result pre="Sciences : Microbiology : Medical Microbiology : Microbial Pathogens :" exact="Viral" post="Pathogens : Orthomyxoviruses: Influenza Viruses : Medicine and Health"/>
  <result pre="Pathology and Laboratory Medicine : Pathogens : Microbial Pathogens :" exact="Viral" post="Pathogens : Orthomyxoviruses: Influenza Viruses : Biology and Life"/>
  <result pre=": Biology and Life Sciences : Organisms : Viruses :" exact="Viral" post="Pathogens : Orthomyxoviruses: Influenza Viruses : People and places"/>
  <result pre=": Biology and Life Sciences : Microbiology : Microbial Evolution:" exact="Viral" post="Evolution : Biology and Life Sciences : Evolutionary Biology"/>
  <result pre="Sciences : Evolutionary Biology : Organismal Evolution : Microbial Evolution:" exact="Viral" post="Evolution : Biology and Life Sciences : Microbiology :"/>
  <result pre="Evolution : Biology and Life Sciences : Microbiology : Virology:" exact="Viral" post="Evolution Dynamic interactions of influenza viruses in Hong Kong"/>
  <result pre="New York, United States of America[2], WHO Collaborating Centre for" exact="Infectious" post="Disease Epidemiology and Control, School of Public Health, Li"/>
  <result pre="York, United States of America[2], WHO Collaborating Centre for Infectious" exact="Disease" post="Epidemiology and Control, School of Public Health, Li Ka"/>
  <result pre="worldwide. Currently, two influenza A subtypes, A(H1N1) and A(H3N2), and" exact="type B" post="viruses co-circulate in humans and infection with one type/subtype"/>
  <result pre="and A(H3N2), and type B viruses co-circulate in humans and" exact="infection" post="with one type/subtype could provide cross-protection against the others."/>
  <result pre="importance of simultaneous monitoring of population immunity, incidence rates, and" exact="viral" post="genetic and antigenic changes. Author summary Three influenza viruses,"/>
  <result pre="of the Hong Kong Government, and the National Institute of" exact="General" post="Medical Sciences (grant U54 GM088558 to the Harvard Center"/>
  <result pre="Sciences (grant U54 GM088558 to the Harvard Center for Communicable" exact="Disease" post="Dynamics). The funders had no role in study design,"/>
  <result pre="morbidity and mortality, leading to 3 to 5 million severe" exact="infections" post="and 291,000 to 646,000 deaths worldwide each year [1,2]."/>
  <result pre="and 291,000 to 646,000 deaths worldwide each year [1,2]. These" exact="recurrent" post="epidemics are a combined outcome of viral antigenic changes,"/>
  <result pre="year [1,2]. These recurrent epidemics are a combined outcome of" exact="viral" post="antigenic changes, interactions among co-circulating influenza viruses, transmission and"/>
  <result pre="A(H1N1) and A(H3N2), and influenza B co-circulate in humans; and" exact="infection" post="of a certain type/subtype can result in partial immunity"/>
  <result pre="humans; and infection of a certain type/subtype can result in" exact="partial" post="immunity to influenza strains of the same type/subtype as"/>
  <result pre="cross-immunity—leads to epidemiological interactions among influenza viruses that, along with" exact="viral" post="antigenic changes, shape influenza phylodynamics and epidemic dynamics [19–31]."/>
  <result pre="transmissibility of an infection, defined as the average number of" exact="secondary" post="infections that arise from a primary infection in a"/>
  <result pre="of an infection, defined as the average number of secondary" exact="infections" post="that arise from a primary infection in a naïve"/>
  <result pre="the average number of secondary infections that arise from a" exact="primary" post="infection in a naïve population. We thus first estimate,"/>
  <result pre="average number of secondary infections that arise from a primary" exact="infection" post="in a naïve population. We thus first estimate, for"/>
  <result pre="1F), although to a less extent for A(H1N1); and for" exact="type B," post="it has only one peak in the winter (Fig"/>
  <result pre="1 Seasonality of influenza epidemics in Hong Kong. Upper panel:" exact="infection" post="rate time series for the three influenza viruses (A)."/>
  <result pre="A(H1N1) (B), A(H3N2) (C), and B (D). Color lines show" exact="infection" post="rates for individuals years during Jan 1998 –July 2018;"/>
  <result pre="addition, the model-inference system was able to accurately estimate the" exact="infection" post="rates during both epidemic and non-epidemic periods for all"/>
  <result pre="seasonal cycle as years with epidemics (Fig 3A), the estimated" exact="infection" post="rates remained at near-zero over these extended time-periods when"/>
  <result pre="not in circulation (Fig 2A). Fig 2 Estimates of weekly" exact="infection" post="rate and population susceptibility for the three types/subtypes: A(H1N1)"/>
  <result pre="variables and parameters, as they are intricately linked to the" exact="infection" post="rate. Foremost, overestimation of population susceptibility would lead to"/>
  <result pre="period) replenishes the susceptible pool whereas gaining of cross-immunity from" exact="infection" post="by other types/subtypes (determined by the strength of cross-immunity)"/>
  <result pre="also be accurate in order to achieve accurate estimation of" exact="infection" post="rate. Taken together, the accurate infection rate estimates suggest"/>
  <result pre="achieve accurate estimation of infection rate. Taken together, the accurate" exact="infection" post="rate estimates suggest that the model-inference system was also"/>
  <result pre="accurately estimate key state variables and parameters. Population susceptibility, R0," exact="infectious" post="period, and immunity period Table 1 summarizes the estimates"/>
  <result pre="for B, respectively. These estimates were consistent with the relative" exact="infection" post="rates of individual types/subtypes. Note, however, due to stringent"/>
  <result pre="full range (in parentheses). Strain Strength of cross-immunity (cij) R0" exact="Infectious" post="period (days) Immunity period (years) A(H1N1) A(H3N2) B A(H1N1)"/>
  <result pre="over the 20-year study period for all types/subtypes. The estimated" exact="infectious" post="period was slightly longer for A(H3N2) (3.0; 2.6–4.3 days)"/>
  <result pre="immunity period determines the duration of immune protection from prior" exact="infection" post="and is thus a key epidemiological parameter shaping the"/>
  <result pre="a wide prior range from 1 to 9 years. The" exact="posterior" post="estimate of immunity period (Table 1 and S7 Fig)"/>
  <result pre="A(H3N2) (2.2; 1.8–2.6 years). These estimates accounted for cross-immunity from" exact="infections" post="of other types/subtypes, for which, after conversion based on"/>
  <result pre="and S7 Fig; cij denotes cross-immunity against virus-i gained from" exact="infection" post="of virus-j). Three interesting features seem to characterize the"/>
  <result pre="among all virus-pairs, cross-immunity was the weakest when gained from" exact="infection" post="of A(H3N2) (the mean was 17% of the strength"/>
  <result pre="As estimated here, i.e., setting all cross-immunity terms to the" exact="posterior" post="mean estimates; 2) A(H3N2) outcompeting A(H1N1) via stronger cross-immunity,"/>
  <result pre="and B currently co-circulating in humans and the pattern of" exact="viral" post="interactions. We have also estimated the timing and frequency"/>
  <result pre="higher for A(H3N2) (range: 1.3–2.0). Estimated simultaneously with R0, the" exact="infectious" post="period, or generation time, was slightly longer for A(H3N2)"/>
  <result pre="A(H1N1); these estimates were very close to those based on" exact="viral" post="shedding curves—3.0 vs 3.1 days reported for A(H3N2), 3.1"/>
  <result pre="the higher transmissibility of A(H3N2) (i.e., larger R0 and longer" exact="infectious" post="period) in part explains its larger seasonal epidemics and"/>
  <result pre="period) in part explains its larger seasonal epidemics and resulting" exact="lower" post="average population susceptibility (mean: 60.8% for A(H3N2) vs. 66.6%"/>
  <result pre="the diverse influenza dynamics in other subtropical/tropical regions or other" exact="infections" post="with similar challenges. Cross-immunity and co-circulation pattern Multiple lines"/>
  <result pre="or other infections with similar challenges. Cross-immunity and co-circulation pattern" exact="Multiple" post="lines of evidence have suggested cross protection offered by"/>
  <result pre="Multiple lines of evidence have suggested cross protection offered by" exact="infection" post="of influenza viruses of the same type/subtype as well"/>
  <result pre="estimate that there were relatively strong cross-immunity against A(H3N2) by" exact="infection" post="of A(H1N1) (~40% of the specific-immunity) and moderate level"/>
  <result pre="estimates of weak cross-immunities to A(H1N1) and B conferred by" exact="infection" post="of A(H3N2) appear to contradict the common notion that"/>
  <result pre="key epidemiological features. In particular, A(H3N2) confers shorter immunity following" exact="infection" post="and also undergoes more frequent genetic/antigenic mutations. Based on"/>
  <result pre="whose first exposure was A(H1N1) had long-term protection against subsequent" exact="infection" post="by the same subtype whereas those first exposed to"/>
  <result pre="the product of these two factors is the decrease in" exact="susceptibility to" post="its complement types/subtypes) allows the two less frequently circulating"/>
  <result pre="estimates from phylogenetic analyses. For instance, the two surges in" exact="susceptibility to" post="A(H1N1) during the 2009 pandemic (i.e., around 9/13/09 and"/>
  <result pre="in estimated influenza attack rates. Recent estimates ranged from 3–11%" exact="symptomatic" post="infections among vaccinated and unvaccinated US residents during 2010–2016"/>
  <result pre="estimated influenza attack rates. Recent estimates ranged from 3–11% symptomatic" exact="infections" post="among vaccinated and unvaccinated US residents during 2010–2016 [56]to"/>
  <result pre="vaccinated and unvaccinated US residents during 2010–2016 [56]to 32% confirmed" exact="infection" post="among unvaccinated individuals during 2015 in New Zealand [57]."/>
  <result pre="relatively high but plausible given the longer epidemic duration and" exact="lower" post="vaccination rates in Hong Kong (~10% [58,59] v. ~45%"/>
  <result pre="monitoring population immunity to different influenza viruses, incidence rates, and" exact="viral" post="genetic and antigenic changes. Meanwhile, the model-inference system developed"/>
  <result pre="extended to study influenza epidemic dynamics in other regions with" exact="limited" post="antigenic data. Materials and Methods Influenza surveillance data The"/>
  <result pre="a more specific measure of the incidence of influenza virus" exact="infections" post="in the community, we multiplied the weekly ILI rate"/>
  <result pre="community, we multiplied the weekly ILI rate by the concurrent" exact="viral" post="isolation rate for A(H1N1), A(H3N2) and B, respectively [42,49,65,66]."/>
  <result pre="as A(H1N1)+, A(H3N2)+, and B+. Converting ILI consultation rate to" exact="infection" post="rate The ILI consultation rate is the ratio of"/>
  <result pre="the catchment population. Previously, we showed that conversion to per-capita" exact="infection" post="rate can be made based on Bayes’ rule [65,67]."/>
  <result pre="pandemic ranged from 16% [68] to ~20% [61,69]. Using the" exact="upper" post="end of these estimates and the cumulative pandemic H1N1+"/>
  <result pre="a particle filter with space re-probing. We further smoothed the" exact="posterior" post="estimates of R0 using 3-week moving average and used"/>
  <result pre="chance of reinfection and transmission in any individual with prior" exact="infection" post="by a similar strain (i.e. leaky immunity) or protect"/>
  <result pre="leaky immunity) or protect a portion of individuals with prior" exact="infection" post="(i.e. polarized immunity). In particular, Gog and Grenfell [24]"/>
  <result pre="βi, Di, and Li are, respectively, the transmission rate, mean" exact="infectious" post="period, and mean immunity period, for virus-i; and cij"/>
  <result pre="cij measures the strength of cross-immunity to virus-i conferred by" exact="infection" post="of virus-j (e.g., close to 0 if it is"/>
  <result pre="and cii = 1 for strain-specific immunity). We assumed the" exact="total" post="population size is stable over the study period such"/>
  <result pre="for strain-specific immunity). We assumed the total population size is" exact="stable" post="over the study period such that the birth rate"/>
  <result pre="the SR-IF2 were uniform distributions as follows: Si~U[50%, 90%] of" exact="total" post="population and Di~U[2, 4] days for i = A(H1N1),"/>
  <result pre="interactions. Note, however, with perturbations in the IF2 procedure, the" exact="posterior" post="estimates can go outside the prior range. Together, we"/>
  <result pre="can go outside the prior range. Together, we tested a" exact="total" post="of 736 combinations of Li and cij priors in"/>
  <result pre="(highest likelihood and fewest space re-probing needed) and used their" exact="posterior" post="estimates to compute the prior range for subsequent round"/>
  <result pre="particles. Each run took round 8 to 10 hours to" exact="complete" post="on a high-performance cluster (https://www.mailman.columbia.edu/information-for/information-technology/high-performance-computing-hpc). To account for stochasticity"/>
  <result pre="(highest likelihood and fewest space re-probing needed) and computed the" exact="posterior" post="estimates across those runs per Rubin’s rule [78,79]. Estimating"/>
  <result pre="rate and population susceptibility (A), basic reproductive number R0 (B)," exact="infectious" post="period (C), immunity period (D), and strength of cross-immunity"/>
  <result pre="box plots show the median, 75%, and 95% CIs of" exact="posterior" post="estimates by the model-inference system; orange dashed lines show"/>
  <result pre="rate and population susceptibility (A), basic reproductive number R0 (B)," exact="infectious" post="period (C), immunity period (D), and strength of cross-immunity"/>
  <result pre="box plots show the median, 75%, and 95% CIs of" exact="posterior" post="estimates by the model-inference system; orange dashed lines show"/>
  <result pre="A(H3N2), and (C) B. Black lines are ILI+ observations; red" exact="horizontal" post="lines are baselines; blue vertical lines are the identified"/>
  <result pre="A(H3N2), and (C) B. Black lines are ILI+ observations; red" exact="horizontal" post="lines are baselines; blue vertical lines are the identified"/>
  <result pre="data file. S7 Fig Weekly estimates of key model parameters:" exact="Infectious" post="period for A(H1N1) (A), A(H3N2) (B), and B (C);"/>
  <result pre="six virus-pairs (G-L). Solid lines and surrounding areas show the" exact="posterior" post="mean and 95% CI estimates and dashed lines show"/>
  <result pre="here for additional data file. S8 Fig Simulations using the" exact="posterior" post="mean estimates. Colored lines show simulated weekly infection rates"/>
  <result pre="using the posterior mean estimates. Colored lines show simulated weekly" exact="infection" post="rates from 1000 individual stochastic model runs (A(H1N1) in"/>
  <result pre="B in green); dashed black lines show the weekly mean" exact="infection" post="rates across 1000 simulations and solid black lines show"/>
  <result pre="was set to 0.5 and other parameters set to the" exact="posterior" post="mean estimates. Colored lines show simulated weekly infection rates"/>
  <result pre="to the posterior mean estimates. Colored lines show simulated weekly" exact="infection" post="rates from 1000 individual stochastic model runs (A(H1N1) in"/>
  <result pre="B in green); dashed black lines show the weekly mean" exact="infection" post="rates across 1000 simulations and solid black lines show"/>
  <result pre="were set to 0 and other parameters set to the" exact="posterior" post="mean estimates. Colored lines show simulated weekly infection rates"/>
  <result pre="to the posterior mean estimates. Colored lines show simulated weekly" exact="infection" post="rates from 1000 individual stochastic model runs (A(H1N1) in"/>
  <result pre="B in green); dashed black lines show the weekly mean" exact="infection" post="rates across 1000 simulations and solid black lines show"/>
  <result pre="(TIF) LINK Click here for additional data file. S11 Fig" exact="Epidemic" post="and co-circulation patterns under different strengths of cross-immunity. Box"/>
  <result pre="plots show the distributions across 1000 simulations using the parameter" exact="posterior" post="estimates, stratified by period of time: All weeks from"/>
  <result pre="susceptible (S) individuals can get infected and move to being" exact="infectious" post="(I), who subsequently recover (R) from the infection; due"/>
  <result pre="lose prior immunity and return to being susceptible. While the" exact="infection" post="processes for each virus happen independently (hence the three"/>
  <result pre="three viruses can occur via cross-immune protection, which convert new" exact="infections" post="by other viruses to a loss of susceptibility (thin"/>
  <result pre="MuscatelloDJ, PalekarR, et al. (2018) Estimates of global seasonal influenza-associated" exact="respiratory" post="mortality: a modelling study. Lancet391: 1285–1300. 10.1016/S0140-6736(17)33293-229248255 3MedinaRA, Garcia-SastreA"/>
  <result pre="virus reduces the induction of heterosubtypic immunity against influenza A/H5N1" exact="virus infection" post="in ferrets. J Virol85: 2695–2702. 10.1128/JVI.02371-1021228239 9EkiertDC, BhabhaG, ElsligerMA,"/>
  <result pre="reduces the induction of heterosubtypic immunity against influenza A/H5N1 virus" exact="infection" post="in ferrets. J Virol85: 2695–2702. 10.1128/JVI.02371-1021228239 9EkiertDC, BhabhaG, ElsligerMA,"/>
  <result pre="2695–2702. 10.1128/JVI.02371-1021228239 9EkiertDC, BhabhaG, ElsligerMA, FriesenRH, JongeneelenM, et al. (2009)" exact="Antibody" post="recognition of a highly conserved influenza virus epitope. Science324:"/>
  <result pre="2 influenza A viruses. Science333: 843–850. 10.1126/science.120483921737702 11EpsteinSL (2006) Prior" exact="H1N1 Influenza" post="Infection and Susceptibility of Cleveland Family Study Participants during"/>
  <result pre="A viruses. Science333: 843–850. 10.1126/science.120483921737702 11EpsteinSL (2006) Prior H1N1 Influenza" exact="Infection" post="and Susceptibility of Cleveland Family Study Participants during the"/>
  <result pre="TsibaneT, KrammerF, HaiR, RahmatS, et al. (2012) 1976 and 2009" exact="H1N1 Influenza" post="Virus Vaccines Boost Anti-Hemagglutinin Stalk Antibodies in Humans. J"/>
  <result pre="BoonAC, SmithLR, TreanorJJ, et al. (2007) Cross-reactive neuraminidase antibodies afford" exact="partial" post="protection against H5N1 in mice and are present in"/>
  <result pre="GuarnacciaT, CarolanL, HormanW, YanA, et al. (2016) The time-interval between" exact="infections" post="and viral hierarchies are determinants of viral interference following"/>
  <result pre="HormanW, YanA, et al. (2016) The time-interval between infections and" exact="viral" post="hierarchies are determinants of viral interference following influenza virus"/>
  <result pre="The time-interval between infections and viral hierarchies are determinants of" exact="viral" post="interference following influenza virus infection in a ferret model."/>
  <result pre="and viral hierarchies are determinants of viral interference following influenza" exact="virus infection" post="in a ferret model. Eur J Immunol46: 685–686. 19AndreasenV"/>
  <result pre="viral hierarchies are determinants of viral interference following influenza virus" exact="infection" post="in a ferret model. Eur J Immunol46: 685–686. 19AndreasenV"/>
  <result pre="20BansalS, MeyersLA (2012) The impact of past epidemics on future" exact="disease" post="dynamics. Journal of theoretical biology309: 176–184. 10.1016/j.jtbi.2012.06.01222721993 21BoniMF, GogJR,"/>
  <result pre="closure and mitigation of pandemic (H1N1) 2009, Hong Kong. Emerging" exact="infectious" post="diseases16: 538–541. 10.3201/eid1603.09121620202441 45LiaoQ, CowlingB, LamWT, NgMW, FieldingR (2010)"/>
  <result pre="VerguE, FergusonNM, LemaitreM, CauchemezS, et al. (2008) Time lines of" exact="infection" post="and disease in human influenza: a review of volunteer"/>
  <result pre="LemaitreM, CauchemezS, et al. (2008) Time lines of infection and" exact="disease" post="in human influenza: a review of volunteer challenge studies."/>
  <result pre="FangVJ, ChanKH, WaiW, et al. (2014) Incidence of influenza virus" exact="infections" post="in children in Hong Kong in a 3-year randomized"/>
  <result pre="Kong in a 3-year randomized placebo-controlled vaccine study, 2009–2012. Clinical" exact="infectious" post="diseases: an official publication of the Infectious Diseases Society"/>
  <result pre="study, 2009–2012. Clinical infectious diseases: an official publication of the" exact="Infectious" post="Diseases Society of America59: 517–524.24825868 54BuddAP, BeachamL, SmithCB, GartenRJ,"/>
  <result pre="2009–2012. Clinical infectious diseases: an official publication of the Infectious" exact="Diseases" post="Society of America59: 517–524.24825868 54BuddAP, BeachamL, SmithCB, GartenRJ, ReedC,"/>
  <result pre="Cohort Effects in Influenza Surveillance Data: Evidence That First Influenza" exact="Infection" post="Affects Later Influenza-Associated Illness. The Journal of infectious diseases220:"/>
  <result pre="First Influenza Infection Affects Later Influenza-Associated Illness. The Journal of" exact="infectious" post="diseases220: 820–829. 10.1093/infdis/jiz20131053844 55NextStrain.org (2019) Real-time tracking of influenza"/>
  <result pre="Seasonal Incidence of Symptomatic Influenza in the United States. Clinical" exact="Infectious" post="Diseases66: 1511–1518. 10.1093/cid/cix106029206909 57HuangQS, BandaranayakeD, WoodT, NewbernEC, SeedsR, et"/>
  <result pre="BandaranayakeD, WoodT, NewbernEC, SeedsR, et al. (2019) Risk Factors and" exact="Attack" post="Rates of Seasonal Influenza Infection: Results of the Southern"/>
  <result pre="Effectiveness Research and Surveillance (SHIVERS) Seroepidemiologic Cohort Study. Journal of" exact="Infectious" post="Diseases219: 347–357. 10.1093/infdis/jiy44330016464 58LeeSS, LeungEH, WongNS (2013) Concerns for"/>
  <result pre="Region (2017) Statistics on 2016/17 Vaccination Programmes/Schemes http://www.chp.gov.hk/en/view_content/26734.html 60Centers for" exact="Disease" post="Control and Prevention (2016) National Early-Season Flu Vaccination Coverage,"/>
  <result pre="61WuJT, LeungK, PereraRA, ChuDK, LeeCK, et al. (2014) Inferring influenza" exact="infection" post="attack rate from seroprevalence data. PLoS Pathog10: e100405410.1371/journal.ppat.100405424699693 62LauEHY,"/>
  <result pre="IpDKM, CowlingBJ (2012) Situational Awareness of Influenza Activity Based on" exact="Multiple" post="Streams of Surveillance Data Using Multivariate Dynamic Linear Model."/>
  <result pre="Based on Multiple Streams of Surveillance Data Using Multivariate Dynamic" exact="Linear" post="Model. Plos One7: e3834610.1371/journal.pone.003834622675456 63LauEHY, CowlingBJ, HoLM, LeungGM (2008)"/>
  <result pre="(2008) Optimizing use of multistream influenza sentinel surveillance data. Emerging" exact="infectious" post="diseases14: 1154–1157. 10.3201/eid1407.08006018598647 64CowlingBJ, WongIO, HoLM, RileyS, LeungGM (2006)"/>
  <result pre="Commun4: 283710.1038/ncomms383724302074 66WongJY, WuP, NishiuraH, GoldsteinE, LauEH, et al. (2013)" exact="Infection" post="fatality risk of the pandemic A(H1N1)2009 virus in Hong"/>
  <result pre="MartchevaM, Castillo-ChavezC (2005) Dynamics of Two-Strain Influenza with Isolation and" exact="Partial" post="Cross-Immunity. SIAM Journal on Applied Mathematics65: 964–982. 73KoelleK, KhatriP,"/>
  <result pre="practice and guidelines. BMC Med Res Methodol9: 5710.1186/1471-2288-9-5719638200 79RubinDB (2004)" exact="Multiple" post="imputation for nonresponse in surveys: John Wiley &amp;amp; Sons."/>
 </snippets>
</snippetsTree>
